The 3 business models that will attract buyers to my high-cost medical device
The global medical devices market is projected to grow at 4.4% CAGR until 2025. But large medical devices with high initial procurement costs are experiencing...
Unlock insights. Activate growth.
CRA’s global expert team supports MedTech clients in developing both product-specific and portfolio/corporate strategies. We rely on our deep understanding of the market environment, extensive prior experience in the MedTech space, and a multidisciplinary approach. Our clients have asked CRA to support them with:
- Product launch: Support successful launch based on relevant external stakeholder dynamics and understanding the best pathway to communicate value and secure funding and reimbursement
- Portfolio enhancement: Optimize the portfolio and analyze internal and external synergies to maximize organization efforts/investments
- Growth strategy: Ensure organic growth by developing strategies to penetrate into new markets or secure a market position and/or inorganic growth by assessing appropriate assets for acquisition through accurate funding and commercial potential analyses
- Market assessment: Understand market opportunities and needs and develop engagement strategies leveraging, but not limited to, digital options
- Organizational excellence: Optimize internal tactics and processes and ensure successful strategic implementation by involving all relevant stakeholders
Expertise across the product lifecycle.
CRA has deep expertise in creating commercial and PMA strategies along the MedTech product lifecycle. We can help you understand, demonstrate, and maximize value.
- Early developmentDiscover
- Business development strategy
- Market, competitor and payer landscaping
- Needs assessment
- Commercial attractiveness vs investment and acquisition requirements
- Forecasting
- Late developmentDevelop
- Stakeholder value drivers and P&MA positioning strategies
- Landscape reviews (analysis of coding, coverage and payment environment, review of reimbursement mechanisms, HTAs, guidelines, and policy documents)
- Tactical product planning (cost-effectiveness and business case for payers, planning and activity templates)
- LaunchDeliver
- Product strategy and launch maximizer (launch excellence)
- P&MA strategy development
- Competitive landscape assessments
- Identification of hurdles for adoption
- Stakeholder engagement strategies
- Life cycleDefend
- Price/access/uptake benchmarking and assessments
- Brand strategy audit
- Growth strategies – market opportunities, product evolution, service offerings
- Competitor defense strategies
- Marketing optimization (salesforce excellence)
Engagements
- 01Commercial opportunity and PMA potential for radiotherapy device supporting novel procedure in cardiologyOur client was preparing to launch an upgrade to their radiotherapy devices and wanted to understand the commercial potential, preferred business models and...View engagement
- 02Optimizing adoption of diagnostic support app evaluating digital health data in primary carePharma client was developing a smartphone application supporting primary care physicians in identifying patients to refer earlier by evaluating digital...View engagement
- 03Understanding the regulatory, P&R and access landscape for medical devicesOur client approached us to map pathways for medical devices used as part of inpatient and ambulatory procedures. Outputs were used to support an internal...View engagement
Meet our team
Recent events
The Future of MedTech and Hospital Relationships in the US Roundtable Discussion
The COVID-19 pandemic has had a significant impact – both positive and negative – on MedTech customers as well as the MedTech industry itself. Almost all...
Roundtable Discussion: COVID-19 Impact on MedTech
The COVID-19 pandemic has had a significant impact – both positive and negative – on MedTech customers as well as the MedTech industry itself. Similar to how...